$32.18
-1.67-4.93%
At close: -
$33.46
1.283.98%
After Hours: 6:02 PM EDT
Harmony Biosciences Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Harmony Biosciences Hldgs using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-25 | $1.08 | $0.82 | 31.7 % |
Q3 | 2024-10-29 | $1.03 | $0.66 | 56.1 % |
Q2 | 2024-08-06 | $1.05 | $-0.06 | 1850.0 % |
Q1 | 2024-04-30 | $0.88 | $0.62 | 41.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-25 | $201.27M | $201.25M | 0.01 % |
Q3 | 2024-10-29 | $186.04M | $184.06M | 1.07 % |
Q2 | 2024-08-06 | $172.81M | $172.53M | 0.16 % |
Q1 | 2024-04-30 | $154.62M | $154.80M | -0.12 % |
Harmony Biosciences Hldgs (HRMY) is scheduled to report earnings on April 29, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
The Actual EPS was $1.08, which beat the estimate of $0.82.
The Actual Revenue was $201.3M, which beat the estimate of $201.3M.
Browse earnings estimates, EPS, and revenue on all stocks.